Investigating the therapeutic role of Leuculectin, a C-type lectin from Bothrops leucurus snake venom, in corneal neovascularization

Posted by
  Investigating the therapeutic role of Leuculectin, a C-type lectin from Bothrops leucurus snake venom, in corneal neovascularization Abstract Pathological corneal neovascularization remains a major therapeutic challenge due to the limited efficacy and safety of currently available antiangiogenic treatments. Although C-type lectins from snake venom possess various biological activities, their potential to modulate pathological ocular angiogenesis has not been explored. This study investigated the antiangiogenic effects of Leuculectin, a C-type lectin isolated from Bothrops leucurus venom using an experimental model of corneal neovascularization (CNV), a HUVEC (human umbilical vein endothelial cell) tube formation assay, and the chick embryo chorioallantoic membrane (CAM) assay. In the HUVEC tube formation assay, Leuculectin demonstrated strong antiangiogenic activity. In the CAM assay, Leuculectin applied at concentrations of 1.5, 2.5 and 3.5 μg/mL significantly decreased new ves...

Antivenom efficacy and Traditional Practices for Snakebite in Brazil: Where Do They Meet?

Posted by

 

Antivenom efficacy and Traditional Practices for Snakebite in Brazil: Where Do They Meet?

Abstract

Snakebite envenoming (SBE) remains a significant public health issue in Brazil, where venom diversity, barriers to timely healthcare, and widespread ethnomedical practices intersect. Venom variability across medically relevant snake species poses important challenges for antivenom design and antigenic coverage in the country. In this context, an integrative review was conducted to examine how venom diversity, antivenom efficacy and protective coverage, and traditional first aid and pre-hospital practices influence the management of snakebite envenoming. Preclinical studies revealed substantial inter- and intraspecific variation in the venoms of Bothrops, Crotalus, Lachesis, and Micrurus species, resulting in heterogeneous venom profiles and biological activities, including lethality that may affect antigenic recognition and neutralization. Although Brazilian antivenoms generally neutralize major toxic activities and reverse life-threatening systemic manifestations of envenoming, there are important limitations in their protective capacity against well-established severe complications such as local tissue damage and neurological syndromes. These limitations are highlighted by the incomplete representation of regional venom diversity in immunization pools and differential toxin immunorecognition. Delayed access to antivenom further worsens clinical outcomes, particularly in remote areas. Concurrently, medicinal plants and first aid and pre-hospital practices were widely used despite limited scientific validation and, in some cases, potential iatrogenic risks to human health. Overall, the available evidence indicates that effective snakebite management in Brazil requires addressing the combined challenges posed by venom variability and current antivenom programs, optimizing antivenom design and coverage, expanding equitable access to healthcare, promoting evidence-based community education, and encouraging the scientific evaluation of safe complementary practices.
Da Silva, W. R. G., Lira, D., Da Cunha Brito, I. M., Justino Vidal, I. S., Lima Bezerra, J. J., Alves, R. R. N., Soares, A. M., Jorge, R. J. B., & Sakamoto, T. (2026). Antivenom efficacy and Traditional Practices for Snakebite in Brazil: Where Do They Meet? Toxicon, 109268. https://doi.org/10.1016/j.toxicon.2026.109268